Capex / expansionFiled on BSE ·
Lord's Mark Industries' promoter sells shares and proposes reinvestment for expansion
Lords Mark Industries · Commercial Services & Supplies
What the filing says
- Promoter Mr. Sachidanand H Upadhyay sold 89,98,598 equity shares on September 29, 2026.
- Sale conducted via open market on BSE, net proceeds of ₹76.18 crore credited to bank account.
- Promoter proposes reinvestment of majority of sale proceeds for strategic expansion of medical device unit.
Original filing
Re-Investment Of Funds Received From Sale Of 89,98,598 Equity Shares By Promoter Mr. Sachidanand Hariram Upadhyay For Medical Device Unit Expansion Of The Company.
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Lords Mark Industries
Other capex / expansion filings this fortnight
- Capex / expansionStudds Accessor.Studds Accessories updates delay and new expected start for Manufacturing Facility-V
- Capex / expansionBondada Engineering LtdBondada Engineering commissions 221.7 MWp solar projects in Q2 FY27
- Capex / expansionJayaswal Neco Industries LtdJayaswal Neco Industries achieves financial closure for 1.5 MnTPA pellet plant expansion
- Capex / expansionACME Solar Holdings LtdACME Solar commissions additional 107.36 MW / 437.49 MWh BESS capacity in Rajasthan
- Capex / expansionLloyds MetalsLloyds Metals & Energy reports record H1FY27 production across key segments
- Capex / expansionAdani Green Energy LtdAdani Green Energy operationalizes 481.9 MW renewable and 6.63 GWh BESS projects
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.
